Historical record - last NADAC effective date: 5/22/2019
Product Information
HYDRALAZINE 100 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1017 per EA under NDC 68462034401. Its NADAC has been published 287 times since Nov 28, 2013.
FDA first approved this application on May 29, 2009. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Hydralazine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462034401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/22/2019
Active Ingredients
HYDRALAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090527FDA Approved
5/29/2009
TE Code
AA
On Market Since
5/29/2009
Pharmacological Classes
Price Statistics
The NADAC for HYDRALAZINE 100 MG TABLET has been published 287 times since Nov 28, 2013, and over the history we have for it it has declined 40.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1017 per EA |
|---|---|
| All-time high | $0.1722 (Feb 12, 2014) |
| All-time low | $0.0890 (Dec 20, 2017) |
| Median price | $0.1220 |
| Average price | $0.1239 |
| Largest weekly change | -29.6% (Sep 21, 2016) |
| Weeks tracked | 287 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-40.6%
Last surveyed May 22, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDRALAZINE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDRALAZINE 100 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1017 per EA (NDC 68462034401), effective May 22, 2019.
How has the price of HYDRALAZINE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDRALAZINE 100 MG TABLET has declined 40.6%. It has been tracked across 287 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDRALAZINE 100 MG TABLET?
Since Nov 28, 2013, the NADAC for HYDRALAZINE 100 MG TABLET has ranged from a low of $0.0890 (Dec 20, 2017) to a high of $0.1722 (Feb 12, 2014), with a median of $0.1220 per EA.
Are there cheaper alternatives to HYDRALAZINE 100 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDRALAZINE 100 MG TABLET, is $0.0746 per EA — about 27% below HYDRALAZINE 100 MG TABLET.
Who manufactures HYDRALAZINE 100 MG TABLET?
HYDRALAZINE 100 MG TABLET (NDC 68462034401) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.